stainless 59c well well done, page-6

better story than most think It disapoints me that people like qqqq can catagorize all biotechs in one bag as over bought/oversold, blue sky nothings.
Each stock needs to be treated on its individual merits.

Ept.

has patents and are applying for more
2-3 years away from commercialisation
large target markets in the bils$
10 years plus of research coming to fruition
cash in bank 10 + mil
costs under control, only 6 employees
Tolhurst - last report had it on as a buy
Lodge- selling to customers as the next cmq!

Point me to another in this position? I need another as good as this.

share price, not interested because I'm not a trader, I'm an investor , already declared my hand on that point.
I'm in till 2006, they're in the bottom drawer for safe keeping.

Know the risk, do your own research (there's plenty in this forum if you look for it.

good luck to those who hold and punt

cheers , stainless